# Amphastar Pharmaceuticals, Inc.: Sodium Bicarbonate Injection shortage reverified (limited availability from this maker)

**Score:** 45/100

| Field | Value |
|---|---|
| Manufacturer | Amphastar Pharmaceuticals, Inc. |
| Drug | Sodium Bicarbonate Injection |
| Dosage form | Injection |
| Therapeutic category | Endocrinology/Metabolism, Gastroenterology, Pediatric |
| Status | Current |
| Stage | Shortage reverified (still listed) |
| Availability | Limited availability |
| Reason | Demand increase for the drug |
| Presentations affected | 1 |
| Package NDCs | 76329-3352-1 |
| Manufacturer supply note | Available on allocation |
| First posted | 2017-03-01 |
| Updated | 2026-10-16 |

## Why this score
- Limited availability.
- Sterile injectable: hospital and 503B demand.

Source: openFDA drug shortages endpoint (U.S. Food and Drug Administration drug shortage list) (https://dps.fda.gov/drugshortages). Last refreshed: 2026-11-04T06:10:12.565Z.
From the openFDA drug shortages endpoint, which mirrors the FDA drug shortage list and can lag it by days. Availability and recovery notes are the manufacturer's own statements to FDA. Company and product level only. Verify with FDA and the manufacturer before acting.